C8 Galactosylceramide (d18:1/8:0), CAS [[41613-16-5]]
Biozol Catalog Number:
TGM-T36323
Supplier Catalog Number:
T36323
Alternative Catalog Number:
TGM-T36323-10MG
Manufacturer:
TargetMol
Category:
Biochemikalien
Alternative Names:
C8 Galactosylceramide (d18:1/8:0)
C8 Galactosylceramide is a synthetic C8 short-chain derivative of known membrane microdomain-forming sphingolipids. It increases the amount delivered and toxicity of doxorubicin in cancerous but not non-cancerous cells when incorporated into the nanoliposomal membrane of nanoliposomal-doxorubicin. C8 Galactosylceramide induces proliferation and cytokine production by splenocytes in vitro at concentrations ranging from 100-1,000 ng/ml but has no effect on natural killer T cell production in vivo. It also activates NF-kappaB production in C6 glioma cells when used at a concentration of 10 µM.
Molecular Weight:
587.83
CAS Number:
[41613-16-5]
Formula:
C32H61NO8
Target:
Others
T36323
* VAT and and shipping costs not included. Errors and price changes excepted
